Literature DB >> 31008597

Polyglutamine Solution-State Structural Propensity Is Repeat Length Dependent.

Ryan S Jakubek, Riley J Workman1, Stephen E White, Sanford A Asher.   

Abstract

Expanded polyglutamine (polyQ) tracts in proteins, which are known to induce their aggregation, are associated with numerous neurodegenerative diseases. Longer polyQ tracts correlate with faster protein aggregation kinetics and a decreased age of onset for polyQ disease symptoms. Here, we use UV resonance Raman spectroscopy, circular dichroism spectroscopy, and metadynamics simulations to investigate the solution-state structures of the D2Q15K2 (Q15) and D2Q20K2 (Q20) peptides. Using metadynamics, we explore the conformational energy landscapes of Q15 and Q20 and investigate the relative energies and activation barriers between these low-energy structures. We compare the solution-state structures of D2Q10K2 (Q10), Q15, and Q20 to determine the dependence of polyQ structure on the Q tract length. We show that these peptides can adopt two distinct monomeric conformations: an aggregation-resistant PPII-like conformation and an aggregation-prone β-strand-like conformation. We find that longer polyQ peptides have an increased preference for the aggregation-prone β-strand-like conformation. This preference may play an important role in the increased aggregation rate of longer polyQ peptides that is thought to lead to decreased neurodegenerative disease age of onset for polyQ disease patients.

Entities:  

Year:  2019        PMID: 31008597      PMCID: PMC7011583          DOI: 10.1021/acs.jpcb.9b01433

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  53 in total

1.  Escaping free-energy minima.

Authors:  Alessandro Laio; Michele Parrinello
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

2.  Scalable molecular dynamics with NAMD.

Authors:  James C Phillips; Rosemary Braun; Wei Wang; James Gumbart; Emad Tajkhorshid; Elizabeth Villa; Christophe Chipot; Robert D Skeel; Laxmikant Kalé; Klaus Schulten
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

3.  Characterizing the conformational ensemble of monomeric polyglutamine.

Authors:  Xiaoling Wang; Andreas Vitalis; Matthew A Wyczalkowski; Rohit V Pappu
Journal:  Proteins       Date:  2006-05-01

4.  UV resonance Raman spectroscopy monitors polyglutamine backbone and side chain hydrogen bonding and fibrillization.

Authors:  Kan Xiong; David Punihaole; Sanford A Asher
Journal:  Biochemistry       Date:  2012-07-12       Impact factor: 3.162

5.  Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity.

Authors:  S Chen; V Berthelier; W Yang; R Wetzel
Journal:  J Mol Biol       Date:  2001-08-03       Impact factor: 5.469

6.  Polyglutamine Fibrils: New Insights into Antiparallel β-Sheet Conformational Preference and Side Chain Structure.

Authors:  David Punihaole; Riley J Workman; Zhenmin Hong; Jeffry D Madura; Sanford A Asher
Journal:  J Phys Chem B       Date:  2016-03-18       Impact factor: 2.991

7.  A toxic monomeric conformer of the polyglutamine protein.

Authors:  Yoshitaka Nagai; Takashi Inui; H Akiko Popiel; Nobuhiro Fujikake; Kazuhiro Hasegawa; Yoshihiro Urade; Yuji Goto; Hironobu Naiki; Tatsushi Toda
Journal:  Nat Struct Mol Biol       Date:  2007-03-18       Impact factor: 15.369

8.  Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells.

Authors:  Wen Yang; John R Dunlap; Richard B Andrews; Ronald Wetzel
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

9.  Formation and toxicity of soluble polyglutamine oligomers in living cells.

Authors:  Patrick Lajoie; Erik Lee Snapp
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

10.  Pathogenic and non-pathogenic polyglutamine tracts have similar structural properties: towards a length-dependent toxicity gradient.

Authors:  Fabrice A C Klein; Annalisa Pastore; Laura Masino; Gabrielle Zeder-Lutz; Hélène Nierengarten; Mustapha Oulad-Abdelghani; Danièle Altschuh; Jean-Louis Mandel; Yvon Trottier
Journal:  J Mol Biol       Date:  2007-05-18       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.